Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04403139 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

VZV-specific Tissue Resident Memory T-cells After Shingrix Vaccination

StatusActive, Not Recruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary and study completion dates: Feb 2026 to Dec 2026v8
  2. Primary and study completion dates: Feb 2025 to Feb 2026 Trial status: Recruiting to Active, Not Recruiting · Site details revisedv7 Show 2 more changesShow less
    • Trial status: Recruiting to Active, Not Recruiting
    • Site details revised
  3. Primary and study completion dates: Feb 2024 to Feb 2025v6
  4. Trial status: Not Yet Recruiting to Recruiting Start date changed from estimate of Mar 2022 to Apr 27, 2022 · Site details revisedv5 Show 2 more changesShow less
    • Start date changed from estimate of Mar 2022 to Apr 27, 2022
    • Site details revised
  5. Start date: Jan 2022 to Mar 2022v4
Show 2 earlier versionsHide 2 earlier versions
  1. Start date: Sep 2020 to Jan 2022v3
  2. Primary endpoints: 1 to 3v2 See this version in full on ClinicalTrials.gov ↗
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
To evaluate the effect of intramuscular RZV vaccine on VZV-specific skin TRM and circulating T-cells
Trial Details
NCT Number NCT04403139
Lead Sponsor University of Washington
Collaborators: National Institute on Aging (NIA)
Conditions Varicella Zoster Virus Infection
Enrollment 50 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov